Logo Image
|Articles|March 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-03-01-2001
  • Volume 0
  • Issue 0

Outbreak: Anthrax Alarm

New Delhi, India-Anthrax, a disease that most commonly infects livestock, has been diagnosed at an increasing rate in humans in the southern states of India. The disease has been eradicated in the developed world but remains endemic in South India, mostly due to a lack of effective human and animal vaccines.

Articles in this issue

over 25 years ago

Research: New Horizons

over 25 years ago

Earnings: Tough Times Ahead

over 25 years ago

Patents: China on the Genome Map

over 25 years ago

Privacy, Pediatrics, and Policy

over 25 years ago

Lilly's International Family

over 25 years ago

Update: Punishment and Reprieve

over 25 years ago

Shortage: Vaccine Worries

over 25 years ago

Gateway to Japan

over 25 years ago

Surrounded

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Tecentriq
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Read more
Naoki Okamura: Post-Patent Plan and Purpose
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.
Read more